SP cells and downstream progenitors in human and mouse muscle
SP cells and downstream progenitors in human and mouse muscle
批准号:
8443428
负责人:
EMANUELA GUSSONI
金额:
$36.0万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-01 至 2015-04-30
关键词:
AblationAgeAreaBMP4Blood CirculationCell TherapyCell modelCellsChickensDevelopmentEndothelial CellsFundingGoalsGreen Fluorescent ProteinsHumanIn VitroInjection of therapeutic agentLeadLifeLocationMethodsModelingMononuclearMusMuscleMuscle CellsMuscle DevelopmentMuscle FibersMuscle satellite cellMyopathyPathologyPericytesPopulationPopulation HeterogeneityRoleSideSignal TransductionSkeletal MuscleSomitesStem cellsTelomeraseTissuesWorkbone morphogenetic protein receptorscell typefetalin vivointerstitialinterstitial cellmouse modelmuscle disorder therapymuscle regenerationmuscular dystrophy mouse modelnovelparacrineprogenitorreceptorregenerativerepairedsatellite cellself-renewalstem
中文摘要
摘要
肌卫星细胞是骨骼肌中研究最多的细胞。他们满足了许多要求,
组织特异性干细胞,包括自我更新和分化成多种细胞类型的能力。在
除了卫星细胞外,还从人和小鼠骨骼肌中分离出了其他肌源性祖细胞,
肌肉.这些“替代性”肌源性祖细胞与卫星细胞不同,
微血管或肌纤维间的间隙中。其中一种“替代性”肌原细胞
这就是所谓的“侧群”(SP)。我们对人体肌肉的研究表明,SP细胞
分泌因子(如BMP 4),诱导表达受体的肌原性祖细胞增殖,
这些因子(BMP-受体1a,BMPR 1a)。在本申请中,我们将阐明
人肌肉SP细胞和BMPR 1a+祖细胞,研究BMPR 1a是否在肌肉SP中强制表达
细胞导致其激活和定向成肌细胞谱系,研究BMPR 1a +
在表达Myf 5或Pax 3的骨骼肌祖细胞中的表达将导致肌肉病理学,并且
在小鼠模型中确定肌肉SP细胞或BMPR 1a+祖细胞是否是“干”样细胞,
内在的高复制能力。这些研究的具体目的,涉及人类和小鼠
目的1:确定人肌肉SP细胞是否是BMPR 1a+肌源性祖细胞的“祖先”;目的
2:评估BMPR 1a在人肌肉SP细胞中的强制表达是否是必要的且足以诱导
目的3:研究BMPR 1a + Myf 5+或
BMPR 1a + Pax 3+祖细胞对肌肉发育很重要,并参与肌肉再生。
目的4:使用m-TERTGFP模型鉴定骨骼肌中表达端粒酶的细胞
并确定它们与肌肉SP、BMPR 1a+细胞或其他肌肉“干”细胞的关系。这些研究将
揭示BMPR 1a在肌肉祖细胞中表达的功能,并阐明人与骨骼肌细胞间的关系。
肌肉SP和BMPR 1a表达细胞。小鼠和人类研究将相互协同,
定义两个物种中每个肌源性细胞群的意义和重要性。
英文摘要
ABSTRACT
Muscle satellite cells are the most studied cells in skeletal muscle. They fulfill many of the requirements of
tissue-specific stem cells, including the ability to self-renew and to differentiate into multiple cell types. In
addition to satellite cells, other myogenic progenitors have been isolated from both human and mouse skeletal
muscle. These 'alternative' myogenic progenitors are distinct from satellite cells and many appear associated
to the microvasculature or in the interstitial spaces between myofibers. One of these 'alternative' myogenic cell
populations is the so-called 'side population' (SP). Our studies in human muscle have proposed that SP cells
secrete factors (such as BMP4) that induce the proliferation of myogenic progenitors expressing receptors for
these factors (BMP-receptor 1a, BMPR1a). In the current application, we will elucidate the ties between
human muscle SP cells and BMPR1a+ progenitors, study whether forced expression of BMPR1a in muscle SP
cells leads to their activation and commitment to the myogenic lineage, investigate if loss of BMPR1a+
expression in skeletal muscle progenitors expressing Myf5 or Pax3 will lead to muscle pathology, and
determine in a mouse model whether muscle SP cells or BMPR1a+ progenitors are 'stem'-like cells with
intrinsic high-replicative capacity. The Specific Aims of these studies, which involve both human and mouse
cells, are: Aim 1: Determine if human muscle SP cells are 'ancestors' of BMPR1a+ myogenic progenitors; Aim
2: Assess if forced expression of BMPR1a in human muscle SP cells is necessary and sufficient to induce
their proliferation and specification towards the myogenic lineage; Aim 3: Investigate if BMPR1a+Myf5+ or
BMPR1a+Pax3+ progenitors are important for muscle development and participate in muscle regeneration in
post-natal life; Aim 4: Use the m-TERT GFP model to identify telomerase-expressing cells in skeletal muscle
and determine their relationship to muscle SP, BMPR1a+ cells or other muscle 'stem' cells. These studies will
unveil the function of BMPR1a expression in muscle progenitors and unravel the relationship between human
muscle SP and BMPR1a-expressing cells. Mouse and human studies will synergize with one another, to
define the significance and importance of each myogenic cell population in both species.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1007/978-1-61779-343-1_1
发表时间:
2012
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Lapan, Ariya D, Gussoni, Emanuela]
通讯作者:
Gussoni, Emanuela
Isolation and immortalization of patient-derived cell lines from muscle biopsy for disease modeling.
从肌肉活检中分离和永生化患者来源的细胞系,用于疾病建模。
DOI:
10.3791/52307
发表时间:
2015
期刊:
Journal of visualized experiments : JoVE
影响因子:
--
作者:
[Robin,JeromeD, Wright,WoodyE, Zou,Yaqun, Cossette,StacyC, Lawlor,MichaelW, Gussoni,Emanuela]
通讯作者:
Gussoni,Emanuela
DOI:
10.1083/jcb.200511036
发表时间:
2006-10-09
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Frank NY, Kho AT, Schatton T, Murphy GF, Molloy MJ, Zhan Q, Ramoni MF, Frank MH, Kohane IS, Gussoni E]
通讯作者:
Gussoni E
Carbamylated erythropoietin does not alleviate signs of dystrophy in mdx mice.
氨甲酰化促红细胞生成素不能减轻 mdx 小鼠的营养不良症状。
DOI:
10.1002/mus.21785
发表时间:
2011
期刊:
Muscle & nerve
影响因子:
3.4
作者:
[Wu,MelissaP, Gussoni,Emanuela]
通讯作者:
Gussoni,Emanuela
Epigenetic dysregulation of muscle differentiation in Kabuki syndrome
-
批准号:10560603
-
项目类别:
-
资助金额:$53.0万
-
财政年份:2022
-
负责人:EMANUELA GUSSONI
-
依托单位:
Epigenetic dysregulation of muscle differentiation in Kabuki syndrome
-
批准号:10342143
-
项目类别:
-
资助金额:$55.34万
-
财政年份:2022
-
负责人:EMANUELA GUSSONI
-
依托单位:
Tetraspanin CD82 in muscle satellite cells quiescence and differentiation
-
批准号:9937662
-
项目类别:
-
资助金额:$37.77万
-
财政年份:2017
-
负责人:EMANUELA GUSSONI
-
依托单位:
Tetraspanin CD82 in muscle satellite cells quiescence and differentiation
-
批准号:9504592
-
项目类别:
-
资助金额:$38.41万
-
财政年份:2017
-
负责人:EMANUELA GUSSONI
-
依托单位:
Tetraspanin CD82 in muscle satellite cells quiescence and differentiation
-
批准号:10362518
-
项目类别:
-
资助金额:$38.55万
-
财政年份:2017
-
负责人:EMANUELA GUSSONI
-
依托单位:
C6ORF32, AN HDAC6-BINDING PROTEIN THAT REGULATES MYOBLAST DIFFERENTIATION
-
批准号:8302345
-
项目类别:
-
资助金额:$39.15万
-
财政年份:2011
-
负责人:EMANUELA GUSSONI
-
依托单位:
C6ORF32, AN HDAC6-BINDING PROTEIN THAT REGULATES MYOBLAST DIFFERENTIATION
-
批准号:8691730
-
项目类别:
-
资助金额:$38.37万
-
财政年份:2011
-
负责人:EMANUELA GUSSONI
-
依托单位:
C6ORF32, AN HDAC6-BINDING PROTEIN THAT REGULATES MYOBLAST DIFFERENTIATION
-
批准号:8185253
-
项目类别:
-
资助金额:$39.08万
-
财政年份:2011
-
负责人:EMANUELA GUSSONI
-
依托单位:
C6ORF32, AN HDAC6-BINDING PROTEIN THAT REGULATES MYOBLAST DIFFERENTIATION
-
批准号:8497627
-
项目类别:
-
资助金额:$37.19万
-
财政年份:2011
-
负责人:EMANUELA GUSSONI
-
依托单位:
Delivery of human muscle SP cells to dystrophic muscle
-
批准号:6943910
-
项目类别:
-
资助金额:$25.75万
-
财政年份:2004
-
负责人:EMANUELA GUSSONI
-
依托单位:
Delivery of human muscle SP cells to dystrophic muscle
-
批准号:6824663
-
项目类别:
-
资助金额:$26.93万
-
财政年份:2004
-
负责人:EMANUELA GUSSONI
-
依托单位:
SP cells and downstream progenitors in human and mouse muscle
-
批准号:8044803
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2004
-
负责人:EMANUELA GUSSONI
-
依托单位:
SP cells and downstream progenitors in human and mouse muscle
-
批准号:8234869
-
项目类别:
-
资助金额:$37.3万
-
财政年份:2004
-
负责人:EMANUELA GUSSONI
-
依托单位:
SP cells and downstream progenitors in human and mouse muscle
-
批准号:7812119
-
项目类别:
-
资助金额:$37.16万
-
财政年份:2004
-
负责人:EMANUELA GUSSONI
-
依托单位:
Delivery of human muscle SP cells to dystrophic muscle
-
批准号:7086169
-
项目类别:
-
资助金额:$25.16万
-
财政年份:2004
-
负责人:EMANUELA GUSSONI
-
依托单位:
Delivery of human muscle SP cells to dystrophic muscle
-
批准号:7259377
-
项目类别:
-
资助金额:$24.43万
-
财政年份:2004
-
负责人:EMANUELA GUSSONI
-
依托单位:
Progenitor Cells inHuman Skeletal Muscle
-
批准号:7802953
-
项目类别:
-
资助金额:$27.48万
-
财政年份:2001
-
负责人:EMANUELA GUSSONI
-
依托单位:
Progenitor Cells inHuman Skeletal Muscle
-
批准号:7588056
-
项目类别:
-
资助金额:$27.62万
-
财政年份:2001
-
负责人:EMANUELA GUSSONI
-
依托单位:
Progenitor Cells inHuman Skeletal Muscle
-
批准号:8049593
-
项目类别:
-
资助金额:$26.86万
-
财政年份:2001
-
负责人:EMANUELA GUSSONI
-
依托单位:
Progenitor Cells inHuman Skeletal Muscle
-
批准号:8232986
-
项目类别:
-
资助金额:$27.35万
-
财政年份:2001
-
负责人:EMANUELA GUSSONI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: